Concord Medical Services Holdings Limited
Concord Medical Services Holdings Limited Fundamental Analysis
Concord Medical Services Holdings Limited (CCM) shows weak financial fundamentals with a PE ratio of -0.02, profit margin of -44.60%, and ROE of 7.22%. The company generates $0.4B in annual revenue with weak year-over-year growth of -28.55%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -15.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze CCM's fundamental strength across five key dimensions:
Efficiency Score
WeakCCM struggles to generate sufficient returns from assets.
Valuation Score
ExcellentCCM trades at attractive valuation levels.
Growth Score
WeakCCM faces weak or negative growth trends.
Financial Health Score
ModerateCCM shows balanced financial health with some risks.
Profitability Score
WeakCCM struggles to sustain strong margins.
Key Financial Metrics
Is CCM Expensive or Cheap?
P/E Ratio
CCM trades at -0.02 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, CCM's PEG of -0.00 indicates potential undervaluation.
Price to Book
The market values Concord Medical Services Holdings Limited at -0.00 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 10.16 times EBITDA. This signals the market has high growth expectations.
How Well Does CCM Make Money?
Net Profit Margin
For every $100 in sales, Concord Medical Services Holdings Limited keeps $-44.60 as profit after all expenses.
Operating Margin
Core operations generate -1.31 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $7.22 in profit for every $100 of shareholder equity.
ROA
Concord Medical Services Holdings Limited generates $-2.42 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Concord Medical Services Holdings Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Concord Medical Services Holdings Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
CCM converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-0.02
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.00
vs 25 benchmark
P/B Ratio
Price to book value ratio
-0.00
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.010
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-1.71
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.42
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.07
vs 25 benchmark
ROA
Return on assets percentage
-0.02
vs 25 benchmark
ROCE
Return on capital employed
-0.11
vs 25 benchmark
How CCM Stacks Against Its Sector Peers
| Metric | CCM Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -0.02 | 29.45 | Better (Cheaper) |
| ROE | 7.22% | 779.00% | Weak |
| Net Margin | -44.60% | -24936.00% (disorted) | Weak |
| Debt/Equity | -1.71 | 0.26 | Strong (Low Leverage) |
| Current Ratio | 0.42 | 4.65 | Weak Liquidity |
| ROA | -2.42% | -19344.00% (disorted) | Weak |
CCM outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Concord Medical Services Holdings Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
6.93%
Industry Style: Defensive, Growth, Innovation
GrowingEPS CAGR
44.54%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
-12.48%
Industry Style: Defensive, Growth, Innovation
Declining